The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.
about
Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint diseaseSLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosusBAFF regulates follicular helper t cells and affects their accumulation and interferon-γ production in autoimmunity.Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice.Multi-scale optical imaging of the delayed type hypersensitivity reaction attenuated by rapamycinIdentification of MAMDC1 as a candidate susceptibility gene for systemic lupus erythematosus (SLE)Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic DiseasesHeat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosusMutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity.Customized molecular phenotyping by quantitative gene expression and pattern recognition analysisT cell CD3ζ deficiency enables multiorgan tissue inflammation.Interstitial lung disease and pulmonary hypertension responsive to low-dose ultraviolet A1 irradiation in lupus.Effects of pristane alone or combined with chloroquine on macrophage activation, oxidative stress, and TH1/TH2 skewness.Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice.Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosusTherapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus.Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunityCharacterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruliUltraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus.Lupus-prone mice fail to raise antigen-specific T cell responses to intracellular infectionDistinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production.Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.The role of VH determinants in systemic lupus erythematosus.Immunopathology and the gene therapy of lupus.TH1-TH2: a procrustean paradigm.TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity.T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.Interferons in autoimmune and inflammatory diseases: regulation and roles.Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis.Interferons as pathogenic effectors in autoimmunity.Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosusA role for sex chromosome complement in the female bias in autoimmune disease.Cytokines in systemic lupus erythematosusCritical role of transmethylation in TLR signaling and systemic lupus erythematosus.Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.T Cell-Associated Cytokines in the Pathogenesis of Sjögren's Syndrome
P2860
Q24796731-DACD6A3D-C0D1-4103-B629-B2DE61F6217FQ24804939-34EE51C1-ECDC-439F-87A5-BC9B2C77CC1CQ30360393-CBCBE03D-D33A-48B9-99E7-84B399B8D139Q30411860-8266A246-4A01-48E8-A6CD-5684FD951256Q30567473-91B784C1-4DB4-4CA0-BF89-3BEA11B723EBQ30973856-CECF6A93-DB98-4D9C-92D7-FB3B01E1B9B7Q33563703-D585D449-E3FB-49B0-9BCC-AFD943D916C4Q33577386-ECC485DB-31D3-45F9-8BAE-63CBB5981580Q33595836-F58F5D6B-135D-4302-B90B-015F7F3E7C5CQ33681038-27553A3D-21FC-4464-9DC1-6DF92108CA80Q33804095-56A9F10C-80ED-4DFC-B271-828C357C65E0Q33951047-7821D651-4170-490F-8A2A-91588A8648BEQ34022374-95F565B6-DC30-4634-9303-1F0506B11A25Q34044394-58652E69-E246-4C1F-96D3-B944DED5739FQ34064253-06C888B6-705A-4514-85D7-EAE9B82CB014Q34106220-739B0AAE-18A3-41C6-933E-D918226F4086Q34170097-442C3A3C-4BCE-46D2-BDAF-3469EC5DDEA8Q34284885-EB58DC6B-43AF-4D62-BBED-C1FC612F9890Q34338299-8BF661F9-5195-4D54-B736-1A4A6547FDADQ34380241-BA13190F-8E0B-4F6C-9503-4B0D0881CB2DQ34411021-50CE857B-DC7A-4DDA-8571-F54C3CD6B5CAQ34435073-F9DE6000-0922-4A36-AF65-62D0FC275ED0Q34877991-3DD003DE-E2DD-4C12-A6B8-0F2198A6BA0DQ34897236-DBAD012E-9BE8-4EF6-8E28-0A24F5C6A2DEQ35045922-8BE6B5B3-2D53-4BD0-A79A-7940B3E51D12Q35122166-844C2B47-5B17-4D75-B45F-486B20D0145AQ35139852-A9CF3952-3750-4B5D-843F-0B364551F53CQ35235610-93FBB483-913F-4EA2-B1B4-A925BD98DCB3Q35558638-7E720D2A-D65C-4B4C-8B50-325BB862AC82Q35603598-3091DBF5-2748-4C45-9DF7-A5BB82E299F3Q35675517-E0BA462E-493C-4601-AE6A-EC78E779C4A2Q36079852-A6587D39-CD31-424A-8963-6818DC20B1FAQ36370602-0F937C3E-B44E-4A8D-8D49-F16E1E60EF55Q36423215-FA69E44B-B3A2-4791-A710-796CCEB8C7B9Q36492750-A1A93CC3-3D89-4A95-BDCB-7BB7AAE03A9FQ36639999-98F9EE23-8110-468B-8C32-239695BC82FAQ36659210-E81A690C-040E-429A-8015-D433A7C46977Q36791474-4CEB8361-29BB-4A1E-ABFD-207448A4AD74Q36951009-EE6453F2-A27E-4AE3-89C5-15799F4A2724Q36957148-858F2408-5223-4005-BE74-6363B8C8D609
P2860
The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of IFN-gamma in syste ...... 1/Th2 paradigm in autoimmunity
@nl
The role of IFN-gamma in syste ...... /Th2 paradigm in autoimmunity.
@ast
The role of IFN-gamma in syste ...... /Th2 paradigm in autoimmunity.
@en
type
label
The role of IFN-gamma in syste ...... 1/Th2 paradigm in autoimmunity
@nl
The role of IFN-gamma in syste ...... /Th2 paradigm in autoimmunity.
@ast
The role of IFN-gamma in syste ...... /Th2 paradigm in autoimmunity.
@en
prefLabel
The role of IFN-gamma in syste ...... 1/Th2 paradigm in autoimmunity
@nl
The role of IFN-gamma in syste ...... /Th2 paradigm in autoimmunity.
@ast
The role of IFN-gamma in syste ...... /Th2 paradigm in autoimmunity.
@en
P2093
P2860
P356
P1476
The role of IFN-gamma in syste ...... /Th2 paradigm in autoimmunity.
@en
P2093
A N Theofilopoulos
B R Lawson
S Koundouris
P2860
P2888
P304
P356
10.1186/AR290
P407
P577
2001-02-14T00:00:00Z
P5875
P6179
1043593536